No major effect of estrogen receptor beta gene RsaI polymorphism on bone mineral density and response to alendronate therapy in postmenopausal osteoporosis-Reference-Cited by-同舟云学术

No major effect of estrogen receptor beta gene RsaI polymorphism on bone mineral density and response to alendronate therapy in postmenopausal osteoporosis

Published:2002-06 Issue:2 Volume:81 Page:147-152
ISSN:0960-0760
Container-title:The Journal of Steroid Biochemistry and Molecular Biology
language:en
Short-container-title:The Journal of Steroid Biochemistry and Molecular Biology

Author:

Arko Barbara,Preželj Janez,Komel Radovan,Kocijančič Andreja,Marc Janja

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference36 articles.

1. Bone density determinants in elderly women: a twin study;Flicker;J. Bone Miner. Res.,1995

2. Genetic determinants of bone mass in adults: a twin study;Pocock;J. Clin. Invest.,1987

3. Genetic factors in determining bone mass;Smith;J. Clin. Invest.,1973

4. The diagnosis of osteoporosis;Kanis;J. Bone Miner. Res.,1994

5. Do genetic markers aid in risk assessment?;Ralston;Osteoporosis Int. Suppl.,1998

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Determinants and Pharmacogenetics of Osteoporosis and Osteoporotic Fracture;Osteoporosis;2020

2. Genetic polymorphisms and their influence on therapeutic response to alendronate-a pilot study;Balneo Research Journal;2019-09-03

3. Pharmacogenetics and Pharmacogenomics of Osteoporosis: Personalized Medicine Outlook;Genetics of Bone Biology and Skeletal Disease;2018

4. SOST polymorphisms and response to alendronate treatment in postmenopausal Chinese women with osteoporosis;Pharmacogenomics;2015-07

5. Association of estrogen receptor beta and estrogen-related receptor alpha gene polymorphisms with bone mineral density in postmenopausal women;MOL CELL BIOCHEM;2015